FDA Premarket Submission Software Documentation

FDA premarket submission software documentation requires determining documentation depth based on device risk profile, then assembling required documents addressing cybersecurity, SBOM, interoperability, and post-market commitments per 2023 FDA guidance for submission integrity and patient safety.

FDA premarket submissions require comprehensive cybersecurity documentation including threat modeling, security controls, and a Software Bill of Materials (SBOM) for third-party components, aligning with 2023 FDA cybersecurity expectations and risk-based guidance for patient safety.

A Software Bill of Materials (SBOM) is needed when preparing FDA premarket submissions for medical devices containing software, particularly connected devices, to document third-party components and support cybersecurity risk assessment per 2023 FDA guidance.

Software documentation depth for FDA submissions is determined by the device's risk profile and classification, with higher-risk devices like Class C requiring more extensive documentation to address potential for serious injury, following risk-based 2023 FDA guidance principles.

The 2023 FDA guidance establishes risk-based cybersecurity expectations for premarket submissions, requiring documented threat modeling, security controls, SBOM, and post-market commitments to ensure submission integrity and patient safety for connected medical devices.

FDA premarket submissions must document post-market commitments including plans for ongoing cybersecurity monitoring, vulnerability management, and software updates, ensuring continued patient safety and regulatory compliance throughout the device lifecycle per 2023 FDA guidance.